Review reveals that early intensive treatment for albuminuria improves outcomes in diabetes-linked kidney disease, indicating potential for kidney damage reversal.
Key Points
Effective management of diabetic kidney disease improves outcomes and reduces albuminuria levels.
Renin-angiotensin-aldosterone system inhibitors and sodium-glucose cotransporter 2 inhibitors show promise in clinical trials.
Early combination treatment appears more beneficial compared to traditional monotherapy methods.
Management of diabetic nephropathy is complex and requires addressing multiple pathophysiological factors.